Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Nucl Med Commun

Retrieve available abstracts of 235 articles:
HTML format
Text format



Single Articles


    August 2017
  1. SHARMA A, Mohan A, Bhalla AS, Vishnubhatla S, et al
    Role of various semiquantitative parameters of 18F-FDG PET/CT studies for interim treatment response evaluation in non-small-cell lung cancer.
    Nucl Med Commun. 2017 Aug 16. doi: 10.1097/MNM.0000000000000723.
    PubMed     Text format     Abstract available


  2. MORRIS M, Saboury B, Chen W, Siegel EL, et al
    Finding the sweet spot for metformin in 18F-FDG-PET.
    Nucl Med Commun. 2017 Aug 10. doi: 10.1097/MNM.0000000000000728.
    PubMed     Text format     Abstract available


  3. SARIKAYA I, Elgazzar AH, Sarikaya A, Alfeeli M, et al
    Normal bone and soft tissue distribution of fluorine-18-sodium fluoride and artifacts on 18F-NaF PET/CT bone scan: a pictorial review.
    Nucl Med Commun. 2017 Aug 3. doi: 10.1097/MNM.0000000000000720.
    PubMed     Text format     Abstract available


  4. HUIZING ED, van Dijk JD, van Dalen JA, Timmer JR, et al
    Minimizing rubidium-82 tracer activity for relative PET myocardial perfusion imaging.
    Nucl Med Commun. 2017;38:708-714.
    PubMed     Text format     Abstract available


    July 2017
  5. LANZA E, Donadon M, Felisaz P, Mimmo A, et al
    Refining the management of patients with hepatocellular carcinoma integrating 11C-choline PET/CT scan into the multidisciplinary team discussion.
    Nucl Med Commun. 2017 Jul 18. doi: 10.1097/MNM.0000000000000719.
    PubMed     Text format     Abstract available


  6. MARAFI F, Esmail A, Rasheed R, Alkandari F, et al
    Novel weight-based dose threshold for 18F-NaF PET-CT imaging using advanced PET-CT systems: a potential tool for reducing radiation burden.
    Nucl Med Commun. 2017 Jul 18. doi: 10.1097/MNM.0000000000000706.
    PubMed     Text format     Abstract available


  7. GORIN MA, Mareshdeh W, Ross AE, Allaf ME, et al
    Uptake of the prostate-specific membrane antigen-targeted PET radiotracer 18F-DCFPyL in elastofibroma dorsi.
    Nucl Med Commun. 2017 Jul 12. doi: 10.1097/MNM.0000000000000716.
    PubMed     Text format     Abstract available


  8. MOREAU A, Giraudet AL, Kryza D, Borson-Chazot F, et al
    Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas.
    Nucl Med Commun. 2017 Jul 12. doi: 10.1097/MNM.0000000000000708.
    PubMed     Text format     Abstract available


  9. DEMIRKAYA O, AlQahtani M, Alsugair A, Aras O, et al
    Analysis of metastatic involvement in bone using anatomical and functional information from 18F-FDG PET/CT.
    Nucl Med Commun. 2017 Jul 12. doi: 10.1097/MNM.0000000000000714.
    PubMed     Text format     Abstract available


  10. LEE JW, Lee EY, Hong SY, Yoo ID, et al
    The clinical significance of technetium-99m methylene diphosphonate bone scintigraphy findings in patients with rhabdomyolysis.
    Nucl Med Commun. 2017 Jul 7. doi: 10.1097/MNM.0000000000000709.
    PubMed     Text format     Abstract available


  11. CIFTCI E, Turgut B, Cakmakcilar A, Erturk SA, et al
    Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
    Nucl Med Commun. 2017 Jul 7. doi: 10.1097/MNM.0000000000000712.
    PubMed     Text format     Abstract available


  12. DONG H, Zhang Z, Guo Y, Zhang H, et al
    The application of technetium-99m-red blood cell scintigraphy in the diagnosis of orbital cavernous hemangioma.
    Nucl Med Commun. 2017 Jul 7. doi: 10.1097/MNM.0000000000000711.
    PubMed     Text format     Abstract available


  13. SHEIKHBAHAEI S, Ahn SJ, Young B, Taghipour M, et al
    Comparative effectiveness: 18F-FDG-PET/CT versus CT for post-treatment follow-up of patients with lung cancer.
    Nucl Med Commun. 2017 Jul 3. doi: 10.1097/MNM.0000000000000707.
    PubMed     Text format     Abstract available


    June 2017
  14. MALLORIE A, Goldring J, Patel A, Lim E, et al
    Assessment of nodal involvement in non-small-cell lung cancer with 18F-FDG-PET/CT: mediastinal blood pool cut-off has the highest sensitivity and tumour SUVmax/2 has the highest specificity.
    Nucl Med Commun. 2017 Jun 27. doi: 10.1097/MNM.0000000000000703.
    PubMed     Text format     Abstract available


  15. YANO K, Nanashima A, Fujii Y, Hiyoshi M, et al
    Preoperative regional maximal removal rate of technetium-99m-galactosyl human serum albumin is correlated with liver functional parameters, but did not predict postoperative morbidity.
    Nucl Med Commun. 2017 Jun 22. doi: 10.1097/MNM.0000000000000702.
    PubMed     Text format     Abstract available


  16. GUO R, Wang J, Zhang M, Zhang M, et al
    Value of 99mTc-MIBI SPECT/CT parathyroid imaging and ultrasonography for concomitant thyroid carcinoma.
    Nucl Med Commun. 2017 Jun 13. doi: 10.1097/MNM.0000000000000692.
    PubMed     Text format     Abstract available


    May 2017
  17. DUBREUIL J, Salles G, Bozzetto J, Tordo J, et al
    Usual and unusual pitfalls of 18F-FDG-PET/CT in lymphoma after treatment: a pictorial review.
    Nucl Med Commun. 2017 May 31. doi: 10.1097/MNM.0000000000000697.
    PubMed     Text format     Abstract available


  18. GOLUBIC AT, Pasini Nemir E, Zuvic M, Mutvar A, et al
    The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values.
    Nucl Med Commun. 2017 May 30. doi: 10.1097/MNM.0000000000000696.
    PubMed     Text format     Abstract available


  19. HAS SIMSEK D, Sanli Y, Kulle CB, Karanlik H, et al
    Correlation of 18F-FDG PET/CT with pathological features and survival in primary breast cancer.
    Nucl Med Commun. 2017 May 26. doi: 10.1097/MNM.0000000000000694.
    PubMed     Text format     Abstract available


  20. GREEN AL, Bagci U, Hussein S, Kelly PV, et al
    Brown adipose tissue detected by PET/CT imaging is associated with less central obesity.
    Nucl Med Commun. 2017 May 15. doi: 10.1097/MNM.0000000000000691.
    PubMed     Text format     Abstract available


  21. SHINJYO M, Naniwa M, Kubo N, Nishimura Y, et al
    Optimal injected dose ratio of a very rapid 1-day protocol of myocardial perfusion imaging with cadmium-zinc-telluride single-photon emission tomography: simulation and phantom study.
    Nucl Med Commun. 2017 May 9. doi: 10.1097/MNM.0000000000000689.
    PubMed     Text format     Abstract available


  22. MA JT, Han CB, Zheng JH, Sun HZ, et al
    Hybrid PET/MRI-based delineation of gross tumor volume in head and neck cancer and tumor parameter analysis.
    Nucl Med Commun. 2017 May 9. doi: 10.1097/MNM.0000000000000687.
    PubMed     Text format     Abstract available


  23. SCHUITEVOERDER D, Grinlington L, Stevens J, Nance R, et al
    Nonvisualized sentinel lymph nodes on lymphoscintigraphy in melanoma: predictive factors and surgical outcomes.
    Nucl Med Commun. 2017;38:383-387.
    PubMed     Text format     Abstract available


  24. HAN J, Liu H, Liu C, Jin H, et al
    Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response.
    Nucl Med Commun. 2017;38:372-382.
    PubMed     Text format     Abstract available


  25. HIPPELAINEN ET, Tenhunen MJ, Maenpaa HO, Heikkonen JJ, et al
    Dosimetry software Hermes Internal Radiation Dosimetry: from quantitative image reconstruction to voxel-level absorbed dose distribution.
    Nucl Med Commun. 2017;38:357-365.
    PubMed     Text format     Abstract available


    April 2017
  26. IBALL GR, Bebbington NA, Burniston M, Edyvean S, et al
    A national survey of computed tomography doses in hybrid PET-CT and SPECT-CT examinations in the UK.
    Nucl Med Commun. 2017 Apr 27. doi: 10.1097/MNM.0000000000000672.
    PubMed     Text format     Abstract available


  27. ARMSTRONG IS, Thomson KE, Rowley LM, McGowan DR, et al
    Harmonizing standardized uptake value recovery between two PET/CT systems from different manufacturers when using resolution modelling and time-of-flight.
    Nucl Med Commun. 2017 Apr 25. doi: 10.1097/MNM.0000000000000682.
    PubMed     Text format     Abstract available


  28. GIZEWSKA A, Witkowska-Patena E, Osiecki S, Mazurek A, et al
    Utility of single-photon emission tomography/computed tomography for sentinel lymph node localization in breast cancer patients.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000676.
    PubMed     Text format     Abstract available


  29. YANG CC, Yang BH, Tu CY, Wu TH, et al
    Low-dose computed tomography scans with automatic exposure control for patients of different ages undergoing cardiac PET/CT and SPECT/CT.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000679.
    PubMed     Text format     Abstract available


  30. PRIAMO J, Adamopoulos D, Rager O, Frei A, et al
    Downstream indication to revascularization following hybrid cardiac PET/MRI: preliminary results.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000680.
    PubMed     Text format     Abstract available


  31. MARUOKA Y, Nagao M, Baba S, Isoda T, et al
    Three-dimensional fractal analysis of 99mTc-MAA SPECT images in chronic thromboembolic pulmonary hypertension for evaluation of response to balloon pulmonary angioplasty: association with pulmonary arterial pressure.
    Nucl Med Commun. 2017 Apr 20. doi: 10.1097/MNM.0000000000000673.
    PubMed     Text format     Abstract available


  32. EVANGELISTA L, Cervino AR, Michieletto S, Saibene T, et al
    Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients.
    Nucl Med Commun. 2017 Apr 13. doi: 10.1097/MNM.0000000000000671.
    PubMed     Text format     Abstract available


  33. UYAMA N, Otsuka H, Shinya T, Otomi Y, et al
    The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
    Nucl Med Commun. 2017 Apr 13. doi: 10.1097/MNM.0000000000000674.
    PubMed     Text format     Abstract available


  34. VENNART NJ, Bird N, Buscombe J, Cheow HK, et al
    Optimization of PET/CT image quality using the GE 'Sharp IR' point-spread function reconstruction algorithm.
    Nucl Med Commun. 2017 Apr 7. doi: 10.1097/MNM.0000000000000669.
    PubMed     Text format     Abstract available


  35. CHISM CB, Ravizzini GC, Macapinlac HA, Pan T, et al
    Quantitative comparison between regularized time-of-flight and OSEM PET reconstructions for small 18F-FDG-avid lesions.
    Nucl Med Commun. 2017 Apr 5. doi: 10.1097/MNM.0000000000000670.
    PubMed     Text format     Abstract available


  36. HAROON A, Syed R, Endozo R, Allie R, et al
    Spectrum of metastatic and nonmetastatic skeletal findings with dual-phase 18F-FECH PET/CT in patients with biochemical relapse of prostate cancer.
    Nucl Med Commun. 2017 Apr 4. doi: 10.1097/MNM.0000000000000665.
    PubMed     Text format     Abstract available


  37. ULANER GA, Mannelli L, Dunphy M
    Value of second-opinion review of outside institution PET-CT examinations.
    Nucl Med Commun. 2017;38:306-311.
    PubMed     Text format     Abstract available


  38. TAYWADE SK, Ramaiah VL, Basavaraja H, Venkatasubramaniam PR, et al
    Prevalence of ECG changes during adenosine stress and its association with perfusion defect on myocardial perfusion scintigraphy.
    Nucl Med Commun. 2017;38:291-298.
    PubMed     Text format     Abstract available


  39. RAO H, Gaur N, Tipre D
    Assessment of diabetic neuropathy with emission tomography and magnetic resonance spectroscopy.
    Nucl Med Commun. 2017;38:275-284.
    PubMed     Text format     Abstract available


    March 2017
  40. KWON SY, Choi EK, Kong EJ, Chong A, et al
    Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio: a multicenter retrospective cohort study.
    Nucl Med Commun. 2017 Mar 16. doi: 10.1097/MNM.0000000000000657.
    PubMed     Text format     Abstract available


  41. NAKAMOTO R, Nakamoto Y, Ishimori T, Nishimatsu K, et al
    Diagnostic performance of a novel dedicated breast PET scanner with C-shaped ring detectors.
    Nucl Med Commun. 2017 Mar 16. doi: 10.1097/MNM.0000000000000661.
    PubMed     Text format     Abstract available


  42. LOPCI E, Grizzi F, Russo C, Toschi L, et al
    Early and delayed evaluation of solid tumours with 64Cu-ATSM PET/CT: a pilot study on semiquantitative and computer-aided fractal geometry analysis.
    Nucl Med Commun. 2017 Mar 3. doi: 10.1097/MNM.0000000000000656.
    PubMed     Text format     Abstract available


  43. LEE SJ, Paeng JC, Goo JM, Lee JM, et al
    Comparative characteristics of quantitative indexes for 18F-FDG uptake and metabolic volume in sequentially obtained PET/MRI and PET/CT.
    Nucl Med Commun. 2017 Mar 1. doi: 10.1097/MNM.0000000000000655.
    PubMed     Text format     Abstract available



  44. News and Views-March 2017.
    Nucl Med Commun. 2017;38:273-274.
    PubMed     Text format    


  45. KERAMIDA G, Winterman N, Wroe E, Aplin M, et al
    Importance of accurate ilio-inguinal quantification in lower extremity lymphoscintigraphy.
    Nucl Med Commun. 2017;38:209-214.
    PubMed     Text format     Abstract available


    February 2017
  46. DUBREUIL J, Giammarile F, Rousset P, Rubello D, et al
    The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma.
    Nucl Med Commun. 2017 Feb 27. doi: 10.1097/MNM.0000000000000649.
    PubMed     Text format     Abstract available


  47. WANG Z, Deng G, Zhang Z, Huang H, et al
    Noninvasive detection of matrix metalloproteinase-9 in atherosclerotic lesions using technetium-99m-labeled single-photon emission computed tomography in vivo.
    Nucl Med Commun. 2017 Feb 23. doi: 10.1097/MNM.0000000000000651.
    PubMed     Text format     Abstract available


  48. LAPA P, Marques M, Costa G, Iagaru A, et al
    Assessment of skeletal tumour burden on 18F-NaF PET/CT using a new quantitative method.
    Nucl Med Commun. 2017 Feb 22. doi: 10.1097/MNM.0000000000000654.
    PubMed     Text format     Abstract available


  49. LIU Y
    The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
    Nucl Med Commun. 2017 Feb 20. doi: 10.1097/MNM.0000000000000652.
    PubMed     Text format     Abstract available


  50. STUBBS M, Chan K, McMeekin H, Navalkissoor S, et al
    Incidence of a single subsegmental mismatched perfusion defect in single-photon emission computed tomography and planar ventilation/perfusion scans.
    Nucl Med Commun. 2017;38:135-140.
    PubMed     Text format     Abstract available


  51. HEIBA SI, Stempler L, Sullivan T, Kolker D, et al
    The ideal dual-isotope imaging combination in evaluating patients with suspected infection of pelvic pressure ulcers.
    Nucl Med Commun. 2017;38:129-134.
    PubMed     Text format     Abstract available


  52. BASU S, Banerjee S
    Developing a dedicated comprehensive alpha-radionuclide therapy program: should this be the vision of the atomic energy programs in the next decade?
    Nucl Med Commun. 2017;38:103-105.
    PubMed     Text format    


  53. JACOBSON AF, White S, Travin MI, Tseng C, et al
    Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure.
    Nucl Med Commun. 2017;38:141-148.
    PubMed     Text format     Abstract available


  54. SANTOS AI, Violante L, Carmona S, Prata A, et al
    Interobserver agreement on cortical tracer transit in 99mTc-MAG3 renography applied to congenital hydronephrosis.
    Nucl Med Commun. 2017;38:124-128.
    PubMed     Text format     Abstract available


  55. ARAZ M, Cayir D, Erdogan M, Ucan B, et al
    Factors affecting the sensitivity of Tc-99m methoxyisobutylisonitrile dual-phase parathyroid single photon emission computed tomography in primary hyperparathyroidism.
    Nucl Med Commun. 2017;38:117-123.
    PubMed     Text format     Abstract available


    January 2017
  56. XU W, Yu S, Ma Y, Liu C, et al
    Effect of different segmentation algorithms on metabolic tumor volume measured on 18F-FDG PET/CT of cervical primary squamous cell carcinoma.
    Nucl Med Commun. 2017 Jan 21. doi: 10.1097/MNM.0000000000000641.
    PubMed     Text format     Abstract available


  57. FONAGER RF, Zacho HD, Albertsen S, Fledelius J, et al
    Observer agreement of treatment responses on planar bone scintigraphy in prostate cancer patients: importance of the lesion assessment method.
    Nucl Med Commun. 2017 Jan 17. doi: 10.1097/MNM.0000000000000643.
    PubMed     Text format     Abstract available


  58. TAGHIPOUR M, Mena E, Kruse MJ, Sheikhbahaei S, et al
    Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.
    Nucl Med Commun. 2017 Jan 17. doi: 10.1097/MNM.0000000000000639.
    PubMed     Text format     Abstract available


  59. YEUNG CS, Musaddaq B, Hare S, Wagner T, et al
    18F-FDG-PET/CT study after lung biopsy in suspected lung cancer patients: time is of the essence.
    Nucl Med Commun. 2017;38:99-100.
    PubMed     Text format    


  60. DUBREUIL J, Tordo J, Rubello D, Giammarile F, et al
    Diffusion-weighted MRI and 18F-FDG-PET/CT imaging: competition or synergy as diagnostic methods to manage sarcoma of the uterus? A systematic review of the literature.
    Nucl Med Commun. 2017;38:84-90.
    PubMed     Text format     Abstract available



  61. News and Views-January 2017.
    Nucl Med Commun. 2017;38:101.
    PubMed     Text format    


  62. ASGHAR O, Arumugam P, Armstrong I, Ray S, et al
    Iodine-123 metaiodobenzylguanidine scintigraphy for the assessment of cardiac sympathetic innervation and the relationship with cardiac autonomic function in healthy adults using standardized methods.
    Nucl Med Commun. 2017;38:44-50.
    PubMed     Text format     Abstract available


  63. BEN AZZOUNA R, Leygnac S, Al-Shoukr F, Rouzet F, et al
    68Ga 'vacuum elution approach' for direct radiolabelling of DOTA-conjugated and NODAGA-conjugated peptides.
    Nucl Med Commun. 2017;38:51-56.
    PubMed     Text format     Abstract available


  64. YADAV MP, Ballal S, Tripathi M, Damle NA, et al
    Post-therapeutic dosimetry of 177Lu-DKFZ-PSMA-617 in the treatment of patients with metastatic castration-resistant prostate cancer.
    Nucl Med Commun. 2017;38:91-98.
    PubMed     Text format     Abstract available


  65. ERWIN WD, Jessop AC, Mar MV, Macapinlac HA, et al
    Qualitative and quantitative comparison of gated blood pool single photon emission computed tomography using low-energy high-resolution and SMARTZOOM collimation.
    Nucl Med Commun. 2017;38:35-43.
    PubMed     Text format     Abstract available


  66. AGARWAL KK, Mukherjee A, St A, Tripathi M, et al
    Incremental value of single-photon emission computed tomography/computed tomography in the diagnosis of active condylar hyperplasia.
    Nucl Med Commun. 2017;38:29-34.
    PubMed     Text format     Abstract available


  67. KUMAR R, Sonkawade RG, Pandey AK, Tripathi M, et al
    Practical experience and challenges in the operation of medical cyclotron.
    Nucl Med Commun. 2017;38:10-14.
    PubMed     Text format     Abstract available


  68. BRESSER PL, Sathekge MM, Makanjee CR, Van Wyk D, et al
    A randomized-controlled study of a modified technique to reduce extracardiac activity in myocardial perfusion imaging.
    Nucl Med Commun. 2017;38:21-28.
    PubMed     Text format     Abstract available


    December 2016
  69. BUCKLEY CJ, Sherwin PF, Smith AP, Wolber J, et al
    Validation of an electronic image reader training programme for interpretation of [18F]flutemetamol beta-amyloid PET brain images.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  70. BOLCAEN J, Acou M, Boterberg T, Vanhove C, et al
    18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  71. YU X, Zhu Y, Wang J, Song X, et al
    Pretreatment metabolic parameters measured by 18F-FDG-PET to predict the outcome of first-line chemotherapy in extensive-stage small-cell lung cancer.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  72. ZHU X, Liao C, Penney BC, Li F, et al
    Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  73. DAOUK J, Bailly P, Bouzerar R, Meyer ME, et al
    Effect of tomographic operator inaccuracies and respiratory motion on PET/CT lung nodule images smearing.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  74. HAIDAR M, Shamseddine A, Panagiotidis E, Jreige M, et al
    The role of 68Ga-DOTA-NOC PET/CT in evaluating neuroendocrine tumors: real-world experience from two large neuroendocrine tumor centers.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available



  75. News and Views-December 2016.
    Nucl Med Commun. 2016;37:1337-1338.
    PubMed     Text format    


  76. KIM H, Lee SJ, Kim JS, Davies-Venn C, et al
    Pharmacokinetics and microbiodistribution of 64Cu-labeled collagen-binding peptides in chronic myocardial infarction.
    Nucl Med Commun. 2016;37:1306-1317.
    PubMed     Text format     Abstract available


  77. MASOLI OH, Redruello M, San Miguel L, Medus J, et al
    Ventricular-arterial coupling assessment using gated single-photon emission computed tomography: relationship with reserve pulse pressure and repolarization abnormalities.
    Nucl Med Commun. 2016;37:1297-1301.
    PubMed     Text format     Abstract available


    November 2016
  78. KABASAKAL L, Demirci E, Nematyazar J, Akyel R, et al
    The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  79. WANG R, Xu B, Guo Z, Chen T, et al
    Suite PET/CT neuroimaging for the diagnosis of Parkinson's disease: statistical parametric mapping analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  80. MA H, Shen G, Liu B, Yang Y, et al
    Diagnostic performance of 18F-FDG PET or PET/CT in restaging renal cell carcinoma: a systematic review and meta-analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  81. DUBREUIL J, Giammarile F, Rousset P, Rubello D, et al
    18F-FDG-PET/CT of peritoneal tumors: a pictorial essay.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available



  82. News and Views-November 2016.
    Nucl Med Commun. 2016;37:1218-20.
    PubMed     Text format    


  83. NGUYEN UC, Al Younis I, Ajmone-Marsan N, Dibbets-Schneider P, et al
    Comparison between a count-based and geometrical approach for the assessment of left ventricular dyssynchrony using myocardial perfusion scintigraphy.
    Nucl Med Commun. 2016;37:1125-35.
    PubMed     Text format     Abstract available


  84. PARK S, Cheon GJ, Paeng JC, Won KS, et al
    Phase analysis of gated myocardial perfusion single-photon emission computed tomography after coronary artery bypass graft surgery: reflection of late reverse remodeling in patients with patent grafts after coronary artery bypass graft surgery.
    Nucl Med Commun. 2016;37:1139-47.
    PubMed     Text format     Abstract available


    October 2016
  85. QIU L, Tu G, Li J, Chen Y, et al
    The role of 18F-FDG PET and PET/CT in the evaluation of primary cutaneous lymphoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  86. SONMEZOGLU K, Vatankulu B, Elverdi T, Akyel R, et al
    The role of 68Ga-DOTA-TATE PET/CT scanning in the evaluation of patients with multiple myeloma: preliminary results.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  87. SAH BR, Stolzmann P, Delso G, Wollenweber SD, et al
    Clinical evaluation of a block sequential regularized expectation maximization reconstruction algorithm in 18F-FDG PET/CT studies.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  88. RUILONG Z, Daohai X, Li G, Xiaohong W, et al
    Diagnostic value of 18F-FDG-PET/CT for the evaluation of solitary pulmonary nodules: a systematic review and meta-analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  89. RASTOGI A, Bhattacharya A, Prakash M, Sharma S, et al
    Utility of PET/CT with fluorine-18-fluorodeoxyglucose-labeled autologous leukocytes for diagnosing diabetic foot osteomyelitis in patients with Charcot's neuroarthropathy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  90. FALLAHI B, Beiki D, Salehi Y, Emami-Ardekani A, et al
    Reverse perfusion pattern in myocardial perfusion imaging using technetium-99m-sestamibi in patients with intermediate risk for coronary artery disease in relation to the time of acquisition and intensity of visceral uptake as artifactual causes.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  91. ALANAZI SF, Alzimami KS, Ghannam MM, Aljammaz IJ, et al
    Quantitative imaging characteristics of zirconium-89 on Gemini Time-Of-Flight PET/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  92. HASSAN A, Riaz S, Zafar W
    Fluorine-18 fluorodeoxyglucose avid thyroid incidentalomas on PET/CT scan in cancer patients: how sinister are they?
    Nucl Med Commun. 2016;37:1069-73.
    PubMed     Text format     Abstract available



  93. NEWS AND VIEWS OCTOBER 2016.
    Nucl Med Commun. 2016;37:1109-10.
    PubMed     Text format    


  94. THAPA P, Ranade R, Ostwal V, Shrikhande SV, et al
    Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer
    Nucl Med Commun. 2016;37:1030-7.
    PubMed     Text format     Abstract available


  95. GEORGIOU M, Loudos G, Fysikopoulos E, Lamprou E, et al
    lambda-Eye: a high-sensitivity gamma imaging probe for axillary sentinel lymph node mapping.
    Nucl Med Commun. 2016;37:1001-9.
    PubMed     Text format     Abstract available


    September 2016
  96. KALSY N, Vinjamuri S
    Should we stop offering indium-111 octreotide scans in favour of gallium-68 PET-CT scans in the UK?
    Nucl Med Commun. 2016.
    PubMed     Text format    


  97. BARRIO M, Czernin J, Yeh MW, Palma Diaz MF, et al
    The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  98. KLUIJFHOUT WP, Vorselaars WM, van den Berk SA, Vriens MR, et al
    Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  99. KAEWPUT C, Vinjamuri S
    Comparison of renal uptake of 68Ga-DOTANOC PET/CT and estimated glomerular filtration rate before and after peptide receptor radionuclide therapy in patients with metastatic neuroendocrine tumours.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  100. HE S, Tang G, Hu K, Wang S, et al
    Preclinical evaluation of 5-([11C]-methyloxy)-L-tryptophan as a potential PET molecular imaging probe.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  101. ONAL C, Torun N, Guler OC, Yildirim BA, et al
    Prognostic value of metabolic response measured by 18F-FDG-PET in oesophageal cancer patients treated with definitive chemoradiotherapy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  102. HALL M, Beadsmoore C, Allen S, Abbotts N, et al
    Coding in nuclear medicine, from examination to tariff: an iterative process.
    Nucl Med Commun. 2016.
    PubMed     Text format    


  103. VOGEL WV, Bloemers MC, van der Heide UA, Beets-Tan RG, et al
    Accuracy of PET/MRI coregistration of cervical lesions.
    Nucl Med Commun. 2016;37:997-8.
    PubMed     Text format    



  104. News and Views-September 2016.
    Nucl Med Commun. 2016;37:999.
    PubMed     Text format    


  105. JIANG Z, Liu Y, Xin C, Zhou Y, et al
    Normal stress-only myocardial single photon emission computed tomography predicts good outcome in patients with coronary artery stenoses between 40 and 70.
    Nucl Med Commun. 2016;37:899-903.
    PubMed     Text format     Abstract available


  106. DAVIDSON T, Komissar O, Goshen E, Shalmon B, et al
    Focal fluorine-18 fluorodeoxyglucose-avid parotid findings in patients with lung cancer: prevalence and characteristics.
    Nucl Med Commun. 2016;37:969-74.
    PubMed     Text format     Abstract available


  107. BAHK YW, Chung YA, Lee UY, Park SI, et al
    Gamma correction 99mTc-hydroxymethylene diphosphonate pinhole bone scan diagnosis and histopathological verification of trabecular contusion in young rats.
    Nucl Med Commun. 2016;37:988-91.
    PubMed     Text format     Abstract available


  108. KANGASMAA TS, Constable C, Hippelainen E, Sohlberg AO, et al
    Multicenter evaluation of single-photon emission computed tomography quantification with third-party reconstruction software.
    Nucl Med Commun. 2016;37:983-7.
    PubMed     Text format     Abstract available


  109. SURIYANTO, Ng EY, Say XJ, Ng CE, et al
    Quantitative means for differentiating renal obstruction by analysing renography by compartmental modelling of renal fluid flow rate.
    Nucl Med Commun. 2016;37:904-10.
    PubMed     Text format     Abstract available


    August 2016
  110. ABIKHZER G, Srour S, Fried G, Drumea K, et al
    Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  111. EVANGELISTA L, Zattoni F, Karnes RJ, Novara G, et al
    Radiolabeled choline PET/CT before salvage lymphadenectomy dissection: a systematic review and meta-analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  112. DADPOUR B, Dabbagh Kakhki VR, Afshari R, Dorri-Giv M, et al
    Myocardial perfusion and left ventricular function indices assessed by gated myocardial perfusion SPECT in methamphetamine abusers.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  113. ARMSTRONG IS, Hoffmann SA
    Activity concentration measurements using a conjugate gradient (Siemens xSPECT) reconstruction algorithm in SPECT/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  114. ADAMS HJ, Kwee TC
    Does interim 18F-FDG-PET response-adapted therapy really benefit advanced-stage Hodgkin lymphoma patients?
    Nucl Med Commun. 2016.
    PubMed     Text format    


  115. MINAMIMOTO R
    Response to 'Commentary to "Evaluation of a new motion correction algorithm in PET/CT: combining the entire acquired PET data to create a single three-dimensional motion-corrected PET/CT image."'.
    Nucl Med Commun. 2016;37:888.
    PubMed     Text format    


  116. HAVARIYOUN G
    Commentary to 'Evaluation of a new motion correction algorithm in PET/CT: combining the entire acquired PET data to create a single three-dimensional motion-corrected PET/CT image'.
    Nucl Med Commun. 2016;37:888.
    PubMed     Text format    


  117. HWANG JP, Lim I, Byun BH, Kim BI, et al
    Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  118. PENCHARZ D, McMeekin H, Wagner T, Wickham F, et al
    Radiation dose of 18F-FDG to lactating breasts, its effect on the effective dose and a more accurate effective dose from 18F-FDG.
    Nucl Med Commun. 2016;37:860-4.
    PubMed     Text format     Abstract available


  119. AKERS SR, Werner TJ, Rubello D, Alavi A, et al
    18F-FDG uptake and clearance in patients with compromised renal function.
    Nucl Med Commun. 2016;37:825-32.
    PubMed     Text format     Abstract available


  120. ZUIN M, Rampin L, Rinuncini M, Picariello C, et al
    Role of myocardial perfusion scintigraphy in predicting global cardiovascular risk and differentiating between patients with moderate and high cardiovascular risk.
    Nucl Med Commun. 2016;37:805-11.
    PubMed     Text format     Abstract available


  121. VANZI E, Berti V, Polito C, Freddi I, et al
    Cerebral metabolic rate of glucose quantification with the aortic image-derived input function and Patlak method: numerical and patient data evaluation.
    Nucl Med Commun. 2016;37:849-59.
    PubMed     Text format     Abstract available


  122. TAN H, Zhang H, Yang W, Fu Y, et al
    Breast-specific gamma imaging with Tc-99m-sestamibi in the diagnosis of breast cancer and its semiquantitative index correlation with tumor biologic markers, subtypes, and clinicopathologic characteristics.
    Nucl Med Commun. 2016;37:792-9.
    PubMed     Text format     Abstract available


    July 2016
  123. VATANKULU B, Isik G, Kocael P, Kuyumcu S, et al
    Do 18F-FDG PET/CT findings have a relationship with histopathological and immunohistochemical factors of breast cancer in men?
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  124. UCAK SEMIRGIN S, Basoglu T, Atmaca Saglik B, Sahin M, et al
    Diagnostic value of additional 18F-FDG PET/CT imaging using a vaginal catheter in patients with paravaginal malignant lesions.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  125. LIU H, Chen Y, Wu S, Song F, et al
    Molecular imaging using PET and SPECT for identification of breast cancer subtypes.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  126. XIAO Y, Wang L, Jiang X, She W, et al
    Diagnostic efficacy of 18F-FDG-PET or PET/CT in breast cancer with suspected recurrence: a systematic review and meta-analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  127. CLEARY JO, Yeung J, McMeekin H, Wilhelm T, et al
    The significance of incidental brain uptake on 68Ga-DOTATATE PET-CT in neuroendocrine tumour patients.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  128. STANGIERSKI A, Kaznowski J, Wolinski K, Jodlowska E, et al
    The usefulness of fluorine-18 fluorodeoxyglucose PET in the detection of recurrence in patients with differentiated thyroid cancer with elevated thyroglobulin and negative radioiodine whole-body scan.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  129. HUANG H, Xiao F, Han X, Zhong L, et al
    Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma.
    Nucl Med Commun. 2016;37:689-98.
    PubMed     Text format     Abstract available


  130. MCMEEKIN H, Wickham F, Barnfield M, Burniston M, et al
    Effectiveness of quality control methods for glomerular filtration rate calculation.
    Nucl Med Commun. 2016;37:756-66.
    PubMed     Text format     Abstract available


  131. SILLANMAKI S, Koivumaki T, Laitinen TM, Hakulinen M, et al
    BMI influence on the reproducibility of ECG-gated myocardial perfusion imaging phase analysis in comparison with novel echocardiographic dyssynchrony estimation methods.
    Nucl Med Commun. 2016;37:767-74.
    PubMed     Text format     Abstract available


  132. GUO C, Zhang C, Liu J, Tong L, et al
    Is Tc-99m sestamibi scintimammography useful in the prediction of neoadjuvant chemotherapy responses in breast cancer? A systematic review and meta-analysis.
    Nucl Med Commun. 2016;37:675-88.
    PubMed     Text format     Abstract available


  133. MCMEEKIN H, Wickham F, Barnfield M, Burniston M, et al
    A systematic review of single-sample glomerular filtration rate measurement techniques and demonstration of equal accuracy to slope-intercept methods.
    Nucl Med Commun. 2016;37:743-55.
    PubMed     Text format     Abstract available


    June 2016
  134. JIMENEZ-BONILLA JF, Banzo I, De Arcocha-Torres M, Quirce R, et al
    Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  135. TEAGLE AR, Gilbert DC, Jones JR, Burkill GJ, et al
    Negative 18F-FDG-PET-CT may exclude residual or recurrent disease in anal cancer.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  136. DEMIRCI E, Sahin OE, Ocak M, Akovali B, et al
    Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  137. JOHANSSON J, Alakurtti K, Joutsa J, Tohka J, et al
    Comparison of manual and automatic techniques for substriatal segmentation in 11C-raclopride high-resolution PET studies.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  138. DE OLIVEIRA COSTA R, Hallack Neto A, Siqueira S, Lage LA, et al
    Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  139. MA Y, Shao X, Shao X, Wang X, et al
    High metabolic characteristics of uterine fibroids in 18F-FDG PET/CT imaging and the underlying mechanisms.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  140. LEE H, Paeng JC, Hong SH, Yoo HJ, et al
    Appropriate margin thresholds for isocontour metabolic volumetry of fluorine-18 fluorodeoxyglucose PET in sarcoma: a hybrid PET/MRI study.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  141. PAL S, Sen S, Das D, Basu S, et al
    Examining a hypothetical quantitative model for better approximation of culprit coronary artery and site of stenosis on 99mTc-sestamibi gated myocardial perfusion SPECT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  142. KLEN R, Noponen T, Koikkalainen J, Lotjonen J, et al
    Evaluation of motion-correction methods for dual-gated cardiac positron emission tomography/computed tomography imaging.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  143. TAGHIPOUR M, Sheikhbahaei S, Trahan TJ, Subramaniam RM, et al
    Value of fourth and subsequent post-therapy follow-up 18F-FDG PET/CT scans in patients with breast cancer.
    Nucl Med Commun. 2016;37:602-8.
    PubMed     Text format     Abstract available


  144. GORLA AK, Sood A, Mittal BR
    Role of choline PET/CT in evaluation of primary and secondary hyperparathyroidism.
    Nucl Med Commun. 2016;37:672.
    PubMed     Text format    


  145. BASU S, Ostwal V
    Observation on enhanced avidity on somatostatin receptor targeted 68Ga-DOTATATE PET-CT following therapy with everolimus and capecitabine-temozolamide: is redifferentiation akin phenomenon a reality in neuroendocrine tumors?
    Nucl Med Commun. 2016;37:669-71.
    PubMed     Text format    


  146. KO KY, Wu YW, Liu CJ, Cheng MF, et al
    Clinical significance of right ventricular activity on treadmill thallium-201 myocardial single-photon emission computerized tomography using cadmium-zinc-telluride cameras.
    Nucl Med Commun. 2016;37:650-7.
    PubMed     Text format     Abstract available


  147. OZDEMIR D, Cuhaci FN, Ozdemir E, Aydin C, et al
    The role of postoperative Tc-99m pertechnetate scintigraphy in estimation of remnant mass and prediction of successful ablation in patients with differentiated thyroid cancer.
    Nucl Med Commun. 2016;37:640-5.
    PubMed     Text format     Abstract available


  148. MANCA G, Tardelli E, Rubello D, Gennaro M, et al
    Sentinel lymph node biopsy in breast cancer: a technical and clinical appraisal.
    Nucl Med Commun. 2016;37:570-6.
    PubMed     Text format     Abstract available


  149. CAYIR D, Demirel K, Korkmaz M, Araz M, et al
    Scintigraphic evaluation of renal functional damage in volatile substance abusers.
    Nucl Med Commun. 2016;37:623-31.
    PubMed     Text format     Abstract available


    May 2016
  150. PASCUAL TN
    Examining Quality Management Audits in Nuclear Medicine Practice as a lifelong learning process: opportunities and challenges to the nuclear medicine professional and beyond.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  151. TRIPATHI M, Agarwal KK, Mukherjee A, Thukral P, et al
    99mTc-DMSA planar imaging versus dual-detector SPECT for the detection of renal cortical scars in patients with CKD-3.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  152. LE Y, Chen Y, Zhou F, Liu G, et al
    Comparative diagnostic value of 18F-fluoride PET-CT versus MRI for skull-base bone invasion in nasopharyngeal carcinoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  153. JIN S, Boktor RR, Kc Man K, Pitman AG, et al
    Normal range of osteoblastic activity in total hip arthroplasties on single-photon emission computed tomography bone scintigraphy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  154. YUAN H, Tong DK, Vardhanabhuti V, Law SY, et al
    PET/CT in the evaluation of treatment response to neoadjuvant chemoradiotherapy and prognostication in patients with locally advanced esophageal squamous cell carcinoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  155. QUARTUCCIO N, Caobelli F, Di Mauro F, Cammaroto G, et al
    Non-18F-FDG PET/CT in the management of patients affected by HNC: state-of-the-art.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  156. KWON HW, Lee HY, Hwang YH, Park HC, et al
    Diagnostic performance of 18F-FDG-labeled white blood cell PET/CT for cyst infection in patients with autosomal dominant polycystic kidney disease: a prospective study.
    Nucl Med Commun. 2016;37:493-498.
    PubMed     Text format     Abstract available


  157. MO SJ, Linder J, Blomstedt P, Granasen G, et al
    Long-term dopamine transporter imaging in Parkinson's disease treated with zona incerta stimulation.
    Nucl Med Commun. 2016;37:499-508.
    PubMed     Text format     Abstract available


  158. BONSEN LR, Aalbersberg EA, Tesselaar M, Stokkel MP, et al
    Cardiac neuroendocrine tumour metastases: case reports and review of the literature.
    Nucl Med Commun. 2016;37:461-5.
    PubMed     Text format     Abstract available


    April 2016
  159. SOLIMAN K, Alenezi A, Alqahtani S
    Variability in the amount of fluorine-18 fluorodeoxyglucose excreted in urine measured from oncology patients during PET/computed tomography imaging.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  160. GUO HH, Moradi F, Iagaru A
    Clinical significance of extraskeletal computed tomography findings on 18F-NaF PET/CT performed for osseous metastatic disease evaluation.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  161. ABDULREZZAK U, Kurt YK, Kula M, Tutus A, et al
    Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  162. PETER J, Houshmand S, Werner TJ, Rubello D, et al
    Novel assessment of global metabolism by 18F-FDG-PET for localizing affected lobe in temporal lobe epilepsy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  163. BEN-HAIM S, Garkaby J, Primashvili N, Goshen E, et al
    Metabolic assessment of Merkel cell carcinoma: the role of 18F-FDG PET/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  164. JODAL L, Hansen SB, Jensen SB
    Impact of contamination with long-lived radionuclides on PET kinetics modelling in multitracer studies.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  165. DAVIDSON T, Goshen E, Eshed I, Goldstein J, et al
    Incidental detection of elastofibroma dorsi on PET-CT: initial findings and changes in tumor size and standardized uptake value on serial scans.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  166. VAN DEN BERG NS, Engelen T, Brouwer OR, Matheron HM, et al
    A pilot study of SPECT/CT-based mixed-reality navigation towards the sentinel node in patients with melanoma or Merkel cell carcinoma of a lower extremity.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  167. HONG JH, Jung US, Min KJ, Lee JK, et al
    Prognostic value of total lesion glycolysis measured by 18F-FDG PET/CT in patients with locally advanced cervical cancer.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  168. FENDLER WP, Bluemel C, Rubello D, Herrmann K, et al
    Have we overcome choline PET/CT for early detection of prostate cancer recurrence?
    Nucl Med Commun. 2016.
    PubMed     Text format    



  169. News and Views--April 2016.
    Nucl Med Commun. 2016;37:435-6.
    PubMed     Text format    


  170. KWEE TC, Gholami S, Werner TJ, Rubello D, et al
    18F-FDG, as a single imaging agent in assessing cancer, shows the ongoing biological phenomena in many domains: do we need additional tracers for clinical purposes?
    Nucl Med Commun. 2016;37:333-7.
    PubMed     Text format    


  171. DAS KJ, Patel CD, Sharma G, Naik N, et al
    Detection of perfusion abnormalities in patients with permanent pacemakers on stress-rest 99mTc-tetrofosmin myocardial perfusion single-photon emission computed tomography: comparison between right ventricular apex and right ventricular outflow tract
    Nucl Med Commun. 2016;37:406-11.
    PubMed     Text format     Abstract available


    March 2016
  172. TAGHIPOUR M, Marcus C, Jones S, Sarangi R, et al
    The value of fourth and subsequent post-treatment 18F-FDG PET/CT scans in the management of patients with non-Hodgkin's lymphoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  173. WANG H, Zhang Y, Yu W, Zhao X, et al
    Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1alpha evaluated by 18F-FDG and 18F-FMISO PET/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  174. DEMIR O, Kose N, Ozkan E, Unluturk U, et al
    Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  175. VIGNE J, De Mil R, Peyronnet D, Hecquard C, et al
    Fractionated elution using the TEKCIS technetium-99m generator.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  176. CALABRIA F, Schillaci O
    The biodistribution of the radiolabeled kinds of choline in male patients, assessed by PET/CT.
    Nucl Med Commun. 2016;37:329-30.
    PubMed     Text format    


  177. SI C, Mok GS, Chen L, Tsui BM, et al
    Design and evaluation of an adaptive multipinhole collimator for high-performance clinical and preclinical imaging.
    Nucl Med Commun. 2016;37:313-21.
    PubMed     Text format     Abstract available


  178. KURISU S, Iwasaki T, Ikenaga H, Watanabe N, et al
    Association of mitral annular velocity with myocardial ischemia assessed by single-photon emission computed tomography in patients with suspected coronary artery disease and preserved ejection fraction.
    Nucl Med Commun. 2016;37:278-82.
    PubMed     Text format     Abstract available


    February 2016
  179. VAN VLIET KE, van Eck-Smit BL, de Jong VM, Goslings JC, et al
    Physiological uptake values of 18F-FDG in long bones of the lower extremity on PET/CT imaging.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  180. STAVROU PZ, Papachristou M, Persakis E, Kouvelis K, et al
    Residual activities of 99mTc-labelled radiopharmaceuticals in routine nuclear medicine practice.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  181. ADAMS HJ, Kwee TC
    18F-FDG-PET is not a useful tool for end-of-treatment response evaluation in peripheral T-cell lymphomas.
    Nucl Med Commun. 2016;37:217.
    PubMed     Text format    


  182. IM HJ, Paeng JC, Cheon GJ, Kim EE, et al
    Feasibility of simultaneous 18F-FDG PET/MRI for the quantitative volumetric and metabolic measurements of abdominal fat tissues using fat segmentation.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  183. JHA AK, Purandare N, Shah SA, Agrawal A, et al
    Is there a correlation between planar scintigraphy after 99mTc-MAA and 90Y administration?
    Nucl Med Commun. 2016;37:107-9.
    PubMed     Text format    


  184. MEINTJES M, Sathekge M, Makanjee CR, Dickson JC, et al
    Comparison of rubidium-82 myocardial blood flow quantification with coronary calcium score for evaluation of coronary artery stenosis.
    Nucl Med Commun. 2016;37:197-206.
    PubMed     Text format     Abstract available


  185. DEMIR Y, Surucu E, Sengoz T, Koc M, et al
    Liver metabolic activity changes over time with neoadjuvant therapy in locally advanced rectal cancer.
    Nucl Med Commun. 2016;37:116-21.
    PubMed     Text format     Abstract available


    January 2016
  186. AL-BULUSHI NK, Abouzied ME
    Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  187. LIU Y
    The role of 18F-FDG PET/CT in the follow-up of well-differentiated thyroid cancer with negative thyroglobulin but positive and/or elevated antithyroglobulin antibody.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  188. AL-MUQBEL KM, Yaghan RJ, Al-Omari MH, Rousan LA, et al
    Clinical relevance of 18F-FDG-negative osteoblastic metastatic bone lesions noted on PET/CT in breast cancer patients.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  189. ZHANG S, Xin J, Sun H, Ma J, et al
    Accuracy of PET/MR image coregistration of cervical lesions.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  190. LIN KH, Lee RC, Liu RS, Chang CY, et al
    The prognostic value of tumor shadow disappearance rate on integrated PET/CT evaluation of solitary pulmonary nodules with low glucose metabolism.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  191. HOWARD BA, Roy Choudhury K, Oldan JD, Pagnanelli RA, et al
    Difference in appearance between prone and supine myocardial perfusion images obtained on a high-efficiency cadmium zinc telluride SPECT camera.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  192. TAWAKOL A, Abdelhafez YG, Osama A, Hamada E, et al
    Diagnostic performance of 18F-FDG PET/contrast-enhanced CT versus contrast-enhanced CT alone for post-treatment detection of ovarian malignancy.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  193. KOBAYASHI N, Inaba Y, Tezuka T, Ike H, et al
    Evaluation of local bone turnover in painful hip by 18F-fluoride positron emission tomography.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  194. CHAN HY, Tsoi A, Wong MP, Ho JC, et al
    Utility of 18F-FDG PET/CT in the assessment of lymphoepithelioma-like carcinoma.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  195. WANG C, Li P, Wu S, Lu J, et al
    The role of fluorine-18 fluorodeoxyglucose PET in prognosis evaluation for stem cell transplantation of lymphoma: a systematic review and meta-analysis.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  196. KAN H, Knol RJ, Lazarenko SV, Wondergem M, et al
    Occurrence of typical perfusion defects attributed to jailed or occluded side branch after ramus descendens anterior stenting in a patient cohort referred for 13NH3 myocardial PET/CT.
    Nucl Med Commun. 2016.
    PubMed     Text format     Abstract available


  197. BASU S, Ranade R, Thapa P
    177Lu-DOTATATE versus 177Lu-EDTMP versus cocktail/sequential therapy in bone-confined painful metastatic disease in medullary carcinoma of the thyroid and neuroendocrine tumour: can semiquantitative comparison of 68Ga-DOTATATE and 18F-fluoride PET-CT
    Nucl Med Commun. 2016;37:100-2.
    PubMed     Text format    


  198. ADAMS HJ, de Klerk JM, Fijnheer R, Heggelman BG, et al
    Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
    Nucl Med Commun. 2016;37:23-9.
    PubMed     Text format     Abstract available


    December 2015
  199. BUCHERT R, Hutton C, Lange C, Hoppe P, et al
    Semiquantitative slab view display for visual evaluation of 123I-FP-CIT SPECT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  200. WILLEGAIGNON J, Pelissoni RA, Lima BC, Sapienza MT, et al
    Prediction of iodine-131 biokinetics and radiation doses from therapy on the basis of tracer studies: an important question for therapy planning in nuclear medicine.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  201. ZHU HJ, Hess S, Rubello D, Goris ML, et al
    The strong but nonspecific relationship between 18F-FDG uptake in the lower-extremity veins and venous thromboembolism.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  202. ARANDA-LARA L, Ferro-Flores G, Ramirez FM, Ocampo-Garcia B, et al
    Improved radiopharmaceutical based on 99mTc-Bombesin-folate for breast tumour imaging.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  203. WILLEGAIGNON J, Braga LF, Sapienza MT, Coura-Filho GB, et al
    Diagnostic reference level: an important tool for reducing radiation doses in adult and pediatric nuclear medicine procedures in Brazil.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  204. LIU C, Zhang Y, Zhang Y, Wang M, et al
    Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  205. MARTINEZ T, Gallego Peinado M, Sanchez Catalicio J, Perez Angel F, et al
    Validation of the leukocyte labeling procedure with a new kit for the preparation of technetium-99m exametazime injection.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  206. SHEIKHBAHAEI S, Marcus C, Wray R, Rahmim A, et al
    Impact of point spread function reconstruction on quantitative 18F-FDG-PET/CT imaging parameters and inter-reader reproducibility in solid tumors.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  207. HOW KIT N, Dugue AE, Sevin E, Allouache N, et al
    Pairwise comparison of 18F-FDG and 18F-FCH PET/CT in prostate cancer patients with rising PSA and known or suspected second malignancy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  208. SHAO X, Shao X, Wang X, Wang Y, et al
    Applications of both time of flight and point spread function in brain PET image reconstruction.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  209. OSBORNE DR, Acuff S
    Whole-body dynamic imaging with continuous bed motion PET/CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


    November 2015
  210. FERNANDES RS, Silva JO, Lopes SC, Chondrogiannis S, et al
    Technetium-99m-labeled doxorubicin as an imaging probe for murine breast tumor (4T1 cell line) identification.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  211. FU Z, Liu M, Li Z, Fan Y, et al
    Is the bullhead sign on bone scintigraphy really common in the patient with SAPHO syndrome? A single-center study of a 16-year experience.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  212. BAHLER L, Holleman F, Booij J, Hoekstra JB, et al
    Interobserver and intraobserver variability for the assessment of brown adipose tissue activity on 18F-FDG PET-CT.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  213. AHMED R, Singh SP, Mittal BR, Rattan V, et al
    Role of fluorine-18 fluoride PET-CT scan in the assessment of unilateral condylar hyperplasia in faciomandibular asymmetry patients: a preliminary study.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  214. YI C, Yu D, Shi X, Zhang X, et al
    The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  215. PETER J, Houshmand S, Werner TJ, Rubello D, et al
    Applications of global quantitative 18F-FDG-PET analysis in temporal lobe epilepsy.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


  216. SHEIKHBAHAEI S, Wray R, Young B, Mena E, et al
    18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinoma: impact on management and utilization of quantitative parameters for patient survival prediction.
    Nucl Med Commun. 2015.
    PubMed     Text format     Abstract available


    September 2015
  217. MALIK D
    Drug-augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: What does the evidence point to?
    Nucl Med Commun. 2015;36:966.
    PubMed     Text format    


  218. SADEGHI R
    Drug augmented hepatobiliary scintigraphy for evaluation of neonatal cholestasis: what does the evidence point to?
    Nucl Med Commun. 2015;36:965.
    PubMed     Text format    


    August 2015

  219. News and Views.
    Nucl Med Commun. 2015;36:863-6.
    PubMed     Text format    


  220. LIU M, Fu Z, Li Q, Di L, et al
    Delayed renal tissue tracer transit in Tc-99m-DTPA renography correlates with postoperative renal function improvement in UPJO patients.
    Nucl Med Commun. 2015;36:833-8.
    PubMed     Text format     Abstract available


  221. TAMAM C, Tamam MO, Yildirim D, Mulazimoglu M, et al
    Diagnostic value of single-photon emission computed tomography combined with computed tomography in relation to MRI on osteochondral lesions of the talus.
    Nucl Med Commun. 2015;36:808-14.
    PubMed     Text format     Abstract available


  222. MALIK D, Khan SH, Ali SW, Rather TA, et al
    Comparison of phenobarbitone and ursodeoxycholic acid in drug-augmented hepatobiliary scintigraphy for excluding the diagnosis of obstructive cholestasis in neonatal cholestasis syndrome.
    Nucl Med Commun. 2015;36:827-32.
    PubMed     Text format     Abstract available


  223. OBARA P, Liu H, Wroblewski K, Zhang CP, et al
    Quantification of metabolic tumor activity and burden in patients with non-small-cell lung cancer: Is manual adjustment of semiautomatic gradient-based measurements necessary?
    Nucl Med Commun. 2015;36:782-9.
    PubMed     Text format     Abstract available


    July 2015
  224. ZARIFMAHMOUDI L, Sadeghi R
    Scattered gamma rays: can they be useful for lymphoscintigraphy imaging?
    Nucl Med Commun. 2015;36:755-6.
    PubMed     Text format    


  225. CROASDALE J
    News and views--July 2015.
    Nucl Med Commun. 2015;36:758-9.
    PubMed     Text format    


  226. WEBB RL, Landau E, Klein D, DiPoce J, et al
    Effects of varying serum glucose levels on 18F-FDG biodistribution.
    Nucl Med Commun. 2015;36:717-21.
    PubMed     Text format     Abstract available


    June 2015

  227. News and views - June 2015.
    Nucl Med Commun. 2015;36:655-6.
    PubMed     Text format    


  228. KITAMURA H, Kono Y, Murano T, Hiroi K, et al
    Estimation of radioactivity in single-photon emission computed tomography for sentinel lymph node biopsy in a torso phantom study.
    Nucl Med Commun. 2015;36:646-50.
    PubMed     Text format     Abstract available


  229. NOZAWA A, Rivandi AH, Kanematsu M, Hoshi H, et al
    Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.
    Nucl Med Commun. 2015;36:573-81.
    PubMed     Text format     Abstract available


    May 2015
  230. YONEYAMA H, Tsushima H, Onoguchi M, Konishi T, et al
    Elimination of scattered gamma rays from injection sites using upper offset energy windows in sentinel lymph node scintigraphy.
    Nucl Med Commun. 2015;36:438-44.
    PubMed     Text format     Abstract available


  231. DE MAN KE, Troch ME, Dobbeleir AA, Duong HP, et al
    Comparison of the EANM and SNM guidelines on diuretic renography in children.
    Nucl Med Commun. 2015;36:486-8.
    PubMed     Text format     Abstract available


  232. LI C, Wen B, Wang L, Feng H, et al
    (9)(9)mTc-labeled single-domain antibody EG2 in targeting epidermal growth factor receptor: an in-vitro and mouse model in-vivo study.
    Nucl Med Commun. 2015;36:452-60.
    PubMed     Text format     Abstract available


    April 2015
  233. YUE B, Tang T
    The use of nuclear imaging for the diagnosis of periprosthetic infection after knee and hip arthroplasties.
    Nucl Med Commun. 2015;36:305-11.
    PubMed     Text format     Abstract available


  234. MAFFIONE AM, Paolini R, Rodella E, Ambrosio C, et al
    Response criteria for malignant lymphoma.
    Nucl Med Commun. 2015;36:398-405.
    PubMed     Text format     Abstract available


  235. DEMIRELLI S, Erkilic M, Oner AO, Budak ES, et al
    Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres.
    Nucl Med Commun. 2015;36:340-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: